Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – NewsMaker
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity
Vancouver, BC, Nov 2, 2020 – (ACN Newswire) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related to the potential development of a diagnostic for evaluating the presence or absence of a T-cell immune response to SARS-CoV-2,…
-
Noosa News22 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News22 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General23 hours agoLabor to squeeze public service, sparking warnings of job losses
-
Noosa News22 hours agoInsurers scramble after severe storms and hail slam southeast Queensland